Safety and Efficacy of Bromodomain and Extra-Terminal Inhibitor INCB057643 in Patients with Relapsed or Refractory Myelofibrosis and Other Advanced Myeloid Neoplasms: A Phase 1 StudyJustin M. Watts, Pankit Vachhani, Alessandro Vannuchhi et al.|Blood|2024Cited by 5